Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Adamson

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Leukemia|November 1, 1994
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancerP C Adamson
Seminars in Hematology|October 1, 1994
Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemiaP C Adamson
Leukemia|January 1, 1994
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancerP C Adamson
Journal of the National Cancer Institute|December 2, 1999
Application of pharmacogenetics to optimization of mercaptopurine dosingF M Balis, P C Adamson
Clinical Chemistry|February 4, 1999
Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate readerB C Widemann, F M Balis, P C Adamson
Pediatric Clinics of North America|April 1, 1991
The child with recurrent solid tumorP C Adamson, M E Horowitz, D G Poplack
Leukemia Research|November 1, 1994
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemiaP C Adamson, D G Poplack, F M Balis
Hematology/Oncology Clinics of North America|October 1, 1990
Pharmacology and drug resistance in childhood lymphoblastic leukemiaP C Adamson, D G Poplack, F M Balis
Cancer Chemotherapy and Pharmacology|February 28, 2001
Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primatesE Fox, R F Murphy, C L McCully, et al.
Clinical Pharmacology and Therapeutics|January 20, 2009
Clinical drug development for childhood cancersF M Balis, E Fox, B C Widemann, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Leukemia|November 1, 1994
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancerP C Adamson
Seminars in Hematology|October 1, 1994
Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemiaP C Adamson
Leukemia|January 1, 1994
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancerP C Adamson
Journal of the National Cancer Institute|December 2, 1999
Application of pharmacogenetics to optimization of mercaptopurine dosingF M Balis, P C Adamson
Clinical Chemistry|February 4, 1999
Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate readerB C Widemann, F M Balis, P C Adamson
Pediatric Clinics of North America|April 1, 1991
The child with recurrent solid tumorP C Adamson, M E Horowitz, D G Poplack
Leukemia Research|November 1, 1994
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemiaP C Adamson, D G Poplack, F M Balis
Hematology/Oncology Clinics of North America|October 1, 1990
Pharmacology and drug resistance in childhood lymphoblastic leukemiaP C Adamson, D G Poplack, F M Balis
Cancer Chemotherapy and Pharmacology|February 28, 2001
Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primatesE Fox, R F Murphy, C L McCully, et al.
Clinical Pharmacology and Therapeutics|January 20, 2009
Clinical drug development for childhood cancersF M Balis, E Fox, B C Widemann, et al.
Pageof 6